The Global Varicella Zoster HHV-3 Infections Market is driven by increasing incidence of viral diseases

The Varicella Zoster HHV-3 Infections Market deals with vaccines and therapeutics used in the treatment and prevention of Varicella and Herpes Zoster infections. These viral infections are caused by the reactivation of the Varicella Zoster virus or the human herpes virus 3, which remains dormant in the nervous system after primary infection (chickenpox). The development of live attenuated vaccines such as Zostavax and Shingrix have significantly boosted the protection against Herpes Zoster and its complications in adults and elderlies.
The Global Varicella Zoster (HHV-3) Infections Market is estimated to be valued at USD 1.79 billion in 2024 and is expected to reach USD 2.52 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031.


Key players operating in the Varicella Zoster HHV-3 Infections market are Cangene Corporation, Novartis, GC Biopharma Corp, Pascoe Pharmazeutische Praeparate GmbH, SK Chemical Co. Ltd. These players are focused on ramping up production capacity and conducting research for developing improved vaccines with high efficacy and long-lasting effect.



The demand for Varicella Zoster HHV-3 Infections Market and vaccines is growing significantly driven by increasing incidence of herpes zoster disease globally, especially among the geriatric population. According to WHO, 1 in 3 people are expected to develop herpes zoster during their lifetime. The economic burden of managing herpes zoster is also substantial.

Varicella Zoster HHV-3 Infections Market – https://www.coherentmi.com/ind....ustry-reports/varice

The Spinal Osteosynthesis Units Market is booming by accelerated aging trends


The spinal osteosynthesis units market involves the use of implants and fixation devices in the spinal fusion procedures for stabilizing and aligning the spinal column. Spinal osteosynthesis units provide internal fixation and immobilization during the healing and fusion process of affected vertebrae. Some common spinal osteosynthesis devices include pedicle screws, rods, plates, hooks, and cages. These devices are made of biocompatible materials like titanium and stainless steel. Pedicle screw fixation systems have emerged as the most widely used type of spinal osteosynthesis unit owing to their pullout strength and rigid construct.

The Spinal Osteosynthesis Units Market is estimated to be valued at USD 10.25 billion in 2024 and is expected to reach USD 19.50 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

Key players operating in the spinal osteosynthesis units are Medtronic, Depuy Synthes, Stryker, Zimmer Biomet, Globus Medical, B. Braun, Orthofix, NuVasive, MicroPort, Abbott.

The growing geriatric population and rising incidence of spinal disorders and injuries are driving the demand for Spinal Osteosynthesis Units Market . According to the United Nations, nearly 23% of the global population will be aged 60 years and above by 2050.



Major players are expanding their global footprint through mergers and acquisitions to capitalize on opportunities in emerging markets. For instance, in 2021, Stryker acquired all the remaining shares of OrthoSpace to expand its international footprint in European markets.

Spinal Osteosynthesis Units Market https://www.coherentmi.com/ind........ustry-reports/sp